Form 4: ALX Oncology Holdings Inc. Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Jaume Pons, President & CSO of ALX Oncology Holdings Inc., sold 1,937 shares of common stock on August 14, 2024, to satisfy tax obligations related to vesting restricted stock units.
Summary
- On August 14, 2024, Jaume Pons, the President & CSO of ALX Oncology Holdings Inc., sold 1,937 shares of common stock.
- The shares were sold at a price of $2.58 per share.
- The transaction was executed to cover the reporting person's tax obligations associated with the vesting of restricted stock units.
- Following the transaction, Jaume Pons directly owns 591,510 shares of ALX Oncology Holdings Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover tax obligations is a common occurrence and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine Form 4 filing, which is common when company executives exercise stock options or sell shares. It provides transparency into insider transactions.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of the stock sale transaction. |
| 08/16/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.